Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastim

Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastim

US Patent 12171804 · Granted Dec 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vitronectin receptor antagonist pharmaceuticals2008
Vitronectin receptor antagonist pharmaceuticals2006
Pharmaceuticals for the imaging of angiogenic disorders2006
Vitronectin receptor antagonist pharmaceuticals2006
Matrix metalloproteinase inhibitors2006
Pharmaceuticals for the imaging of angiogenic disorders2004
Vitronectin receptor antagonist pharmaceuticals2003
Pharmaceuticals for the imaging of angiogenic disorders2003
Vitronectin receptor antagonist pharmaceuticals2003
Radiopharmaceuticals for imaging infection and inflammation2002
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the 2000
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the 1999